Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade
Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Down 12% in 4 Weeks, Here's Why Crescent Capital BDC (CCAP) Looks Ripe for a Turnaround
Crescent Capital BDC (CCAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Crescent Capital BDC, Inc. (CCAP) Q4 2025 Earnings Call Transcript
Crescent Capital BDC, Inc. (CCAP) Q4 2025 Earnings Call Transcript
Cream Rises To The Top: 2 Top-Tier BDCs To Buy
Most BDC investors are value investors, who focus on income. The higher the multiple, the lower the yield - i.e., a mechanic that leads "bargain hunters" underemphasizing high P/NAV BDCs. In the article I detail why this kind of approach might be suboptimal.
Crescent Capital: Lower SOFR And 2026 Debt Wall Increase Dividend Coverage Risk
Crescent Capital's 27% NAV discount overstates upside; the BDC's yield looks attractive, but NII pressures and refinancing risks cap total returns. Portfolio risk and unitranche exposure are manageable, but mid-market sponsor lending is a crowded, commoditised space with no moat. Falling SOFR reduces net interest income, while 2026 debt maturities at higher rates further squeeze earnings and dividend coverage.
Crescent Capital BDC, Inc. (CCAP) Q3 2025 Earnings Call Transcript
Crescent Capital BDC, Inc. ( CCAP ) Q3 2025 Earnings Call November 13, 2025 12:00 PM EST Company Participants Daniel McMahon - Senior VP & Head of Public Investor Relations Jason Breaux - Chief Executive Officer Henry Chung - President Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James & Associates, Inc., Research Division Mickey Schleien - Clear Street LLC Christopher Nolan - Ladenburg Thalmann & Co. Inc., Research Division Presentation Operator Good morning, and welcome to the Crescent Capital BDC, Inc.'s Third Quarter ended September 30, 2025 Earnings Conference Call. [Operator Instructions] Please note that Crescent Capital BDC, Inc. may be referred to as CCAP, Crescent BDC or The Company throughout the call.
Crescent Capital BDC (CCAP) Misses Q3 Earnings and Revenue Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.64 per share a year ago.
Analysts Estimate Crescent Capital BDC (CCAP) to Report a Decline in Earnings: What to Look Out for
Crescent Capital BDC (CCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Crescent Capital: Buy This 11% Yield Before The Market Rerates It
CCAP offers a compelling 11% dividend yield and trades at a steep 22% discount to NAV, providing a strong margin of safety. The portfolio is anchored by 91% first-lien loans and 99% sponsor-backed positions, helping to ensure high credit quality and stability. Recent earnings show improving NII coverage and special dividends, supporting both income and total return potential for investors.
Is the Options Market Predicting a Spike in Crescent Capital Stock?
Investors need to pay close attention to Crescent Capital stock based on the movements in the options market lately.
Crescent Capital BDC, Inc. (CCAP) Q2 2025 Earnings Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q2 2025 Earnings Conference Call August 14, 2025 12:00 PM ET Company Participants Daniel McMahon - Senior VP & Head of Public Investor Relations Gerhard Pieter Lombard - Chief Financial Officer Henry Sahn Chung - President Jason A. Breaux - Chief Executive Officer Conference Call Participants Christopher Nolan - Ladenburg Thalmann Mickey Max Schleien - Ladenburg Thalmann & Co. Inc., Research Division Robert James Dodd - Raymond James & Associates, Inc., Research Division Operator Good morning, and welcome to Crescent Capital BDC, Inc. Second Quarter Ended June 30, 2025 Earnings Conference Call.
Crescent Capital BDC (CCAP) Q2 Earnings Match Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.59 per share a year ago.
